期刊文献+

经前平颗粒治疗经前期综合征肝气逆证大鼠的作用机制 被引量:4

Mechanism of Jingqianping Granules in Treating Premenstrual Syndrome Liver-qi Invasion Model Rats
下载PDF
导出
摘要 目的:通过观察经前平颗粒对经前期综合征(PMS)肝气逆证大鼠下丘脑、顶区皮质5羟色胺和多巴胺受体亚型表达的影响,探讨经前平颗粒治疗PMS肝气逆证的机制。方法:制备PMS肝气逆症大鼠模型,经前平给药后心脏灌流4%多聚甲醛固定液,免疫组化法检测大鼠顶区皮质、下丘脑5-HT1AR、D3R阳性细胞。结果:经前平颗粒能使模型大鼠顶区皮质、下丘脑5-HT1A和D3受体阳性细胞明显增多(P<0.05)。结论:经前平颗粒可通过调节中枢5-HT1AR和D3R受体的表达,治疗PMS肝气逆证及相关的情志障碍。 Objective: To approach the mechanism by observing the effects of Jingqianping granules on the expression levels of hypotypes of 5-hydroxytryptamine receptors (5-HTIAR) and dopamine receptors (D3R) in hypothalamuses and parietal region cortexes of the premenstrual syndrome (PMS) liver-qi invasion model rats. Methods: The rat model of PMS liver-qi invasion was established for the administrations of Jingqianping granules. After the treatment, the heart was perfused with 4% polyoxymethylene, and the positive cells of 5-HT1AR and D3R were checked in the hypothalamuses and parietal region cortexes by immunohistochemistry. Results: Jingqianping granules can increase the masculine cells of 5-HT1AR and D3R in the hypothalamuses and parietal region cortexes of the model rats. Conclusions: Jingqianping granules can cure premenstrual syndrome liver-qi invasion and relative affectional disorders by accommodating the central expressions of-HT1AR and D3R.
出处 《药学与临床研究》 2010年第2期152-155,共4页 Pharmaceutical and Clinical Research
基金 国家自然科学基金(30930110 30973688)
关键词 PMS肝气逆证 经前平颗粒 免疫组织化学 5-HT1A受体 D3受体 PMS liver-qi invasion Jingqianping capsule Immunohistochemistry 5-HT1AR D3R
  • 相关文献

参考文献11

二级参考文献41

  • 1高冬梅,乔明琦,张惠云,王海军.经前期综合征肝气郁证猕猴模型评价指标[J].中医杂志,2005,46(12):931-933. 被引量:14
  • 2乔明琦,张惠云,于艳红,慈玉珍,徐旭杰,叶青,陈雨振.经前期综合征肝气逆证患者月经周期血清雌二醇、孕酮含量的动态变化[J].中医杂志,2006,47(4):295-297. 被引量:28
  • 3傅宗翰.论肝[J].中医杂志,1980,21(6):404-404.
  • 4Kebabian J W, Calne D B. Multiple receptors for dopamine.Nature, 1979, 277(5692): 93-96.
  • 5Clark D, White F J. D1 dopamine receptor-the search for a function: a critical evaluation of the D 1/D2 dopamine receptor classification and its functional implications. Synapse,1987, 1(4): 347-388.
  • 6Sokoloff P, Giros B, Martres M P, et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 1990, 347(6289): 146-151.
  • 7Chio C L, Lajiness M E, Huff R M. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. MolPharmacol, 1994, 45(1): 51-60.
  • 8MacKenzie R G, VanLeeuwen D, Pugsley T A, et al. Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur J Pharmacol, 1994, 266(1):79-85.
  • 9Cox B A, Rosser M P, Kozlowski M R, et al. Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse, 1995, 21(1): 1-9.
  • 10Freedman S B, Patel S, Marwood R, et al. Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther, 1994, 268(1): 417-425.

共引文献145

同被引文献87

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部